GYNFO.COM ENEWS

July 10, 2002

 
Dr. Birken would like to take this opportunity to respond to the Houston Chronicle Article dated July 10, 2002 on Prempro. This article can be viewed at "Click for more information" below.

Understanding the Issues from the Recently Released Study Information Regarding Hormone Replacement Therapy

The National Heart, Lung, and Blood Institute of the National Institutes of Health stopped a major clinical trial on the risks and benefits of combination hormone therapy (estrogen and progestin) in healthy menopausal women due to an increased risk of invasive breast cancer.
The trial, part of the Women’s Health Initiative (WHI), also found a small increase in coronary artery disease, stroke, and pulmonary embolism.
The investigators reported a decrease rate of both hip fractures and colon cancers in the study group.
It is important to note that no increase in breast cancer was found among those women who were taking estrogen alone without the addition of progestin.
Here is another way of interpreting the results:
If 10,000 women taking the combined hormone therapy for one year were compared to 10,000 not taking HRT, you would see:
8 more cases of invasive breast cancer
7 more cases of heart attacks
8 more cases of stroke
8 more cases of blood clots in the lungs
6 less cases of colorectal cancer
5 less cases of hip fracture

The increased breast cancer risk did not appear in the first four years of HRT, risks for blood clots were greatest in the first two years of use, and the reduced risk of colorectal cancer was seen after three years of hormone use.


An American College of Obstetricians and Gynecologists Task Force will decide on clinical recommendations within the near future. Until then, my patients have the following options based on these clinical scenarios:

For those patients taking Prempro 2.5 or Prempro 5:
1. May stop this HRT without a need for tapering the medication
2. Switch to another estrogen/progestin (although we have no clinical data on these hormones exist at this time)
3. Stop HRT and switch to soy/black cohosh herbal product
4. Stop HRT and continue to eat nutritional well, exercise, and take Calcium 1200-1500 mg./day with Vitamin D 400 I.U./day
For those patients taking another estrogen/progestin product:
1. Continue on this product until further data is available
2. Stop this product without tapering the medication
3. Switch to a soy/black cohosh product
4. Continue with good nutrition, exercise, and calcium and vitamin D
For those patients taking estrogen only:
1. Continue on ERT until further data is available
2. Stop ERT without tapering the medication
3. Switch to a soy/black cohosh product
4. Continue with good nutrition, exercise, and calcium and vitamin D
For those patients who have been on HRT or ERT less than four years:
1. Continue on this product and stop at four years
2. Stop the product without tapering the medication
3. Switch to a soy/black cohosh product
4. Continue with good nutrition, exercise, and calcium and vitamin D

Remember, no conclusive studies have shown that an herbal product such as soy/black cohosh gives one the assumed benefits of HRT without the risk. Some patients have experienced less hot flashes and night sweats when on these products. Please choose products that are from a reputable source. If you like, there is a link on my home page on Vitamins and Herbs that will take you to Rexall/Unicity, a company that produces excellent products. Look up either Meno-basics or Meno-Essentials and read about these products before purchasing them.

Every patient must be managed on an individual basis since every patient is unique. If you have further questions or concerns, please call the office to schedule a consultation with me. And please remember, don’t panic! These new findings must be analyzed and interpreted by experts before specific guidelines are available to our patients!

The information contained in this information regarding HRT and in our online site is solely intended to provide broad consumer understanding and knowledge of health care topics. This service is for educational purposes only and should in no way be taken to be the provision or practice of medical, nursing or professional healthcare advice or services. The information should not be considered complete and should not be used in place of a visit, call, consultation or advice of your physician or other health care provider. The information obtained from GYNFO.COM is not exhaustive and does not cover all diseases, ailments, physical conditions or their treatments. Should you have any health care-related questions, please call or see your physician or other health care provider promptly.
 

 

Randy A. Birken, M.D.
17070 Red Oak Drive, Suite 201 A - Houston, TX 77090
Office: 281.893.1246
  Fax: 281.444.6259

Copyright 2002 Randy A. Birken, M.D., www.gynfo.com All Right Reserved
Disclaimer and Privacy Policy